Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced that Daniel Paterson, Chief Business Officer, has been appointed to the role of Chief Operating Officer, effective December 12, 2014.
“On behalf of the Board of Directors and the entire management team, we wholeheartedly congratulate Dan on his promotion to Chief Operating Officer,” said Robert Forrester, Verastem President and Chief Executive Officer. “Dan has been instrumental in building a promising portfolio of product candidates; including our lead product VS-6063 which is in development in 12 countries. We look forward to his continued contributions in his new role.”
Help employers find you! Check out all the jobs and post your resume.
